Kentucky · 2025 Regular Session · Bill
HB 685: AN ACT relating to the 340B Drug Pricing Program.
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
HB 685 is a bill introduced in the Kentucky House on February 18, 2025. According to its official title, it concerns: AN ACT relating to the 340B Drug Pricing Program. Most recent recorded action (February 26, 2025): to Health Services (H).
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official summary
Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.
Create a new section of KRS Chapter 216 to define terms; require nonprofit hospitals to submit a 340B Drug Pricing Program report to the Cabinet for Health and Family Services by July 1, 2026, and annually thereafter; direct the Personnel Cabinet to submit a report to the Legislative Research Commission on the impact of the 340B Drug Pricing Program on the Kentucky Employee Health Plan no later than December 1, 2025; require the Cabinet for Health and Family Services to submit a report to the Legislative Research Commission on the impact of the 340B Drug Pricing Program on Medicaid no later than December 1, 2025.
Sponsors
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| No sponsor recorded in source data. | ||||
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- to Health Services (H)
- to Committee on Committees (H)
- introduced in House